Skip to main content
Daily market wrap · Monday, 20 July 2026
~2 min read

Nifty holds but internals keep slipping — treat it with suspicion

Fast breadth eroding, net Stage-2 flow negative, and Thursday's 1.1% index gain masked a 703-to-1,498 rout.
Stage2Stocks Market Desk
Nifty 50
24,239
-0.4% on the day
Regime
Weak but recovering
34th day · neutral-to-up
Breadth
43%
above 200-DMA · narrow
Adv / Dec
1,145 / 1,072
advancers ahead
52w highs / lows
166 / 95
net +71
Stage-2 share
34%
cohort widening

The tape is hollowing out, not dipping inside strength. Nifty sits at 24,238.5, down 0.4% and below its 200-day average, but the real story is that participation has been deteriorating for five straight sessions while the index treads water — that is distribution, not consolidation. Until the fast breadth gauge stops sliding and the Stage-2 flow turns net positive, surface-level index stability is noise.

What the internals are saying

The slow structural gauge — the share of stocks above their 200-day average — has barely moved, sitting at 43%, which looks stable. The fast short-term gauge tells a different story: it peaked at 52% on 13 July and has ground down to 42% today, with Thursday's 1.1% index pop accompanied by only 703 advancers against 1,498 decliners and net new highs collapsing to 39 — the worst reading in this six-session window. Today's advance-decline of 1,145 to 1,072 is marginally positive but does nothing to repair that damage. Over the last five days, 60 stocks rotated out of Stage 2 into Stage 3 against only 46 moving in the other direction — a net drain of 14 — and the Stage-2 cohort itself has slipped from 35.2% to 34.3% over the same stretch. The trajectory is breadth eroding, and a single day of mild advancer leadership does not change that verdict.

Where leadership sits

Defensives led on the day — Utilities up 1.6%, Health Care up 1.2%, Materials up 0.8% — which is not the sector rotation you want to see if you are arguing for a resumption of the prior advance. Health Care is the one sector where the structural case holds: it leads over one month and three months, and its Stage-2 cohort is expanding fastest among all sectors, with Wanbury and RPG Life Sciences both clearing the screen. Consumer Discretionary and Information Technology are also seeing their Stage-2 cohorts widen, though IT remains a three-month laggard at -4.5% and that expansion is coming off a low base. The screen surfaces names — the setups table below shows what cleared today — but in a tape where participation is shrinking and net Stage-2 flow is negative, fewer of those setups will follow through than the scores alone suggest.

Leading Stage-2 setups
StockSectorSetup% 1D
Tirupati Forge LtdConsumer Discretionary10.0
Lokesh Machines LtdIndustrials9.8
Wanbury LtdHealth Care9.3
Signpost India LtdCommunication Services9.3
Triveni Engineering and Industries LtdConsumer Staples9.3
RPG Life Sciences LtdHealth Care9.2
Bharat Seats LtdConsumer Discretionary9.0
Gandhar Oil Refinery (INDIA) LtdEnergy9.0
Sector performance — cap-weighted, ranked by today’s move
Sector1D1M3MRSStage 2
Utilities+1.6%-1.0%+6.3%6318%
Health Care+1.2%+6.7%+17.6%7451%
Materials+0.8%-0.6%+2.5%6934%
Communication Services+0.7%+3.7%+10.7%6518%
Consumer Staples+0.6%-0.4%+0.8%5527%
Industrials+0.4%-1.2%+10.7%6838%
Energy+0.2%+0.9%-1.0%5629%
Consumer Discretionary+0.0%+2.3%+4.0%6736%
Real Estate-0.1%+10.1%+15.5%5225%
Information Technology-0.3%+1.5%-4.5%4028%
Financials-0.3%+0.9%-0.4%6135%
Breadth note
166 stocks are at or near new 52-week highs today — broad participation.
Work the same data live: open the full stock screener, watch the live market dashboard, or check the market-timing regime read. New to the method? Start with the four stages.

Stage2Stocks is an educational stage-analysis screener. These wraps describe what the screen shows across NSE cash equities — they are not investment advice, recommendations, or buy/sell calls. Always do your own research.

More market wraps